- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Inhaled corticosteriod/long-acting beta-agonist only
Total 2611 results
-
Astellas Pharma IncCompletedRenal ImpairmentUnited States
-
Neutec Ar-Ge San ve Tic A.ŞWithdrawn
-
University of California, San DiegoRecruiting
-
Ain Shams UniversityRecruiting
-
National Taiwan University HospitalCompletedRecurrence of Overactive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompleted
-
Giulio StefaniniAgenzia Italiana del FarmacoActive, not recruitingLymphoma, Large B-Cell, Diffuse | Breast Cancer | Chemotherapy Effect | Cardiotoxicity | Left Ventricular DysfunctionItaly
-
Forest LaboratoriesCompleted
-
Milton S. Hershey Medical CenterCompleted
-
Douglas Mental Health University InstituteCanadian Institutes of Health Research (CIHR)Unknown
-
Imperial College LondonAstraZenecaCompleted
-
Daniel Burdick, MDAstellas Pharma US, Inc.Completed
-
HealthPartners InstituteCompletedOveractive Bladder | Parkinson Disease | Impaired CognitionUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Icahn School of Medicine at Mount SinaiForest LaboratoriesCompletedHypertension | Left Ventricular Diastolic DysfunctionUnited States
-
Chinese University of Hong KongTerminated
-
Rhode Island HospitalRecruitingCarpometacarpal Sprain | Thumb Sprain | Clostridium; BotulinumUnited States
-
Commissariat A L'energie AtomiqueNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisUnknownParadoxical Fall in Maximum Expiratory FlowsFrance
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Minneapolis Heart Institute FoundationForest LaboratoriesTerminatedCoronary Artery DiseaseUnited States
-
Velicept Therapeutics, Inc.CompletedHealthy Subjects, Overactive Bladder
-
Astellas Pharma IncCompleted
-
Oregon Health and Science UniversityActive, not recruitingObesity | Cardiovascular Risk Factor | Circadian DysregulationUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive
-
Samsung Medical CenterCompleted
-
Jack RubinsteinForest LaboratoriesTerminated
-
Mylan Bertek PharmaceuticalsCompleted
-
University of Tennessee Graduate School of MedicineMylan Pharmaceuticals IncRecruiting
-
Université de SherbrookeLaval UniversityCompleted
-
Forest LaboratoriesMylan LaboratoriesTerminated
-
Mylan Bertek PharmaceuticalsCompletedHypertensionUnited States
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark, Poland
-
Tianjin Medical University General HospitalRecruiting
-
Mylan Bertek PharmaceuticalsCompletedHypertensionUnited States
-
Clinical Hospital Center ZemunWithdrawnBisoprolol Adverse Reaction | Nebivolol Adverse ReactionSerbia
-
University of MinnesotaForest LaboratoriesCompletedHypertensionUnited States
-
Mayo ClinicCompletedOsteoporosis, Age-RelatedUnited States
-
University of ChicagoForest LaboratoriesCompletedHypertension | DiabetesUnited States
-
Forest LaboratoriesUnknownHypertensionUnited States
-
Vanderbilt UniversityCompletedMetabolic SyndromeUnited States
-
Creighton UniversityWithdrawn
-
University Hospitals Cleveland Medical CenterWithdrawnOveractive BladderUnited States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland
-
Astellas Pharma IncCompletedHealthy Subjects | Bioavailability | Pharmacokinetics of MirabegronNetherlands
-
Forest LaboratoriesCompletedHypertensionUnited States
-
Astellas Pharma Global Development, Inc.TerminatedPharmacokinetics of Mirabegron | Overactive Bladder (OAB)Korea, Republic of, Russian Federation, Turkey
-
Forest LaboratoriesCompletedHypertensionUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany